BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 9480158)

  • 21. [The current possibilities for using plasmacytapheresis (hemapheresis) methods].
    Kalinin NN
    Ter Arkh; 1994; 66(7):68-70. PubMed ID: 7985135
    [No Abstract]   [Full Text] [Related]  

  • 22. Establishment of new national proficiency testing schemes for leucodepleted blood components: UK.
    Seghatchian J
    Transfus Sci; 1999 Aug; 21(1):97-100. PubMed ID: 10724788
    [No Abstract]   [Full Text] [Related]  

  • 23. [Leukocyte depletion by in-line-filtration].
    Krandick E; Vornwald A; Gossrau E
    Beitr Infusionsther Transfusionsmed; 1994; 32():6-8. PubMed ID: 9480158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leukocyte depletion for safe blood transfusion.
    Singh S; Kumar A
    Biotechnol J; 2009 Aug; 4(8):1140-51. PubMed ID: 19418471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Leukodepletion of labile blood products].
    Vignon D
    Ann Pharm Fr; 1999 Jan; 57(1):61-7. PubMed ID: 10073051
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of leukodepletion filters for the removal of bacteria.
    Dzik W
    Immunol Invest; 1995; 24(1-2):95-115. PubMed ID: 7713609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukocyte filtration mechanisms. Factors influencing the removal of infectious agents from red cell concentrates.
    Steneker I; Pietersz RN; Reesink HW
    Immunol Invest; 1995; 24(1-2):87-93. PubMed ID: 7713608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 2.